Medfinder
Back to blog

Updated: January 28, 2026

How Does the Adenovirus Vaccine Work? Mechanism of Action Explained in Plain English

Author

Peter Daggett

Peter Daggett

Blog header image

The Adenovirus Type 4 and Type 7 Vaccine is a cleverly engineered live oral vaccine that replicates in the gut to build immunity. Here's how it works—in plain English.

The Adenovirus Type 4 and Type 7 Vaccine, Live, Oral works in a fundamentally different way from most vaccines most people have encountered. It is not an injection that delivers inactivated virus or mRNA. It is a live oral vaccine in pill form that works by intentionally causing a harmless intestinal infection that triggers the immune system to build lasting protection.

This mechanism of action is elegant and specific—and it is the reason why the tablets must never be chewed or crushed, why the vaccine is so effective at preventing respiratory illness, and why vaccinated recruits shed the virus in their stool for up to 28 days after vaccination.

Step 1: The Enteric Coating Protects the Virus Through the Stomach

When a military recruit swallows the two adenovirus vaccine tablets whole, the critical first step is getting the live virus safely past the acidic environment of the stomach without being destroyed. This is accomplished through a specialized enteric coating on each tablet.

The enteric coating is designed to remain intact in the low-pH (acidic) environment of the stomach and dissolve only in the higher-pH (less acidic) environment of the intestine. The outer tablet layer contains cellulose acetate phthalate, which acts as the enteric barrier. The inner core tablet contains the live adenovirus along with standard pharmaceutical excipients.

This is why the tablets must never be chewed or crushed—breaking the tablet would destroy the enteric coating, releasing live adenovirus in the mouth, throat, and upper respiratory tract where it could cause respiratory illness. The entire efficacy and safety of the vaccine depends on the tablets reaching the intestine intact.

Step 2: The Virus Replicates in the Intestinal Tract

Once the tablets dissolve in the small intestine and release the live adenovirus, something intentional happens: the virus replicates within the intestinal epithelium. This is not an accident—it is the essential mechanism by which the vaccine works. The adenovirus strains used in the vaccine are wild-type viruses that naturally infect intestinal cells efficiently and cause asymptomatic or minimally symptomatic intestinal infections.

In healthy individuals with no pre-existing immunity to these adenovirus types, the intestinal infection is typically mild or even silent—most recruits don't experience obvious GI illness from the vaccine itself. The intestinal infection can cause some mild GI symptoms (nausea, diarrhea) in some individuals, but these are usually temporary and self-limiting.

Step 3: The Immune System Builds Systemic and Mucosal Antibodies

As the adenovirus replicates in the intestine, the immune system mounts a response. The body produces two critical types of immunity:

Systemic (blood-based) immunity: The body produces neutralizing antibodies (IgG) in the bloodstream that can circulate throughout the body and prevent adenovirus from establishing a respiratory infection. The development of neutralizing antibodies with a titer of ≥1:8 is the primary endpoint for Type 7 efficacy in clinical trials.

Mucosal immunity: The intestinal immune system also produces secretory IgA antibodies at mucosal surfaces—including the respiratory mucosa. This local mucosal immunity is believed to be a key component of protection against respiratory adenovirus infection.

This dual immunity—systemic plus mucosal—is why oral live vaccines like this one can be so effective at preventing respiratory illness, even though the vaccine is delivered through the gut rather than the respiratory tract. The immune memory cells created during this response persist in the body long-term, providing ongoing protection.

Why the Vaccine Virus Is Shed in Stool

Because the vaccine works by establishing an intestinal infection, the replicating virus is shed in stool—this is called fecal shedding. Studies have shown that fecal shedding of vaccine strain virus begins approximately 7 days post-vaccination in most vaccinees. In pharmacodynamics studies:

Vaccine virus was shed in the stool starting approximately day 7 following vaccination

Of 30 vaccine recipients, Type 4 fecal shedding was detected in some recipients, and Type 7 shedding was detected in 60% of recipients

No adenovirus shedding was detectable in any subject by day 28 following vaccination

Importantly, vaccine strain virus was NOT detected in throat swabs of any subject — confirming the vaccine does not cause respiratory infection

The fecal shedding of vaccine virus is the basis for the 28-day precautions around hand hygiene and contact with vulnerable populations. The shed virus can potentially cause disease in people who have not been vaccinated—particularly pregnant women, young children, and immunocompromised individuals who are at higher risk of serious adenovirus illness.

Why This Vaccine Must Be Taken Whole (Not Chewed)

This is one of the most important instructions for vaccine recipients, and it flows directly from the mechanism of action. If the enteric coating is broken—by chewing, crushing, or breaking the tablet—the live adenovirus would be released in the mouth and oropharynx (throat). From there, it could:

Infect the upper respiratory tract, potentially causing respiratory illness in the vaccinated person

Be transmitted to others through respiratory droplets before the person even leaves the vaccination room

Reduce the amount of virus reaching the intestine, potentially reducing vaccine efficacy

How Long Does Immunity from the Vaccine Last?

The duration of immunity following the Adenovirus Vaccine has not been formally characterized beyond the study period. Because the vaccine induces an actual infection (rather than just antigen exposure), it is expected to produce long-lasting B-cell and T-cell memory similar to natural infection. In practice, a single vaccination at basic training is considered sufficient for the duration of a service member's exposure risk in the training environment.

For a complete overview of the vaccine's uses and dosing instructions, see: What Is the Adenovirus Vaccine? Uses, Dosage, and What You Need to Know.

To understand drug interactions that can interfere with the vaccine's mechanism, see: Adenovirus Vaccine Drug Interactions: What to Avoid and What to Tell Your Doctor.

Frequently Asked Questions

The vaccine has an enteric coating that protects the live virus from stomach acid, ensuring it reaches the intestine intact where it can replicate and trigger immune response. Chewing or crushing the tablet would break this protective coating, releasing live adenovirus in the throat and potentially causing respiratory illness or transmission to others before reaching the intestine.

The vaccine works by establishing a deliberate intestinal infection with live adenovirus Types 4 and 7. As the virus replicates in the intestinal epithelium to trigger immunity, viral particles are shed in stool—a natural consequence of the intestinal infection. Shedding typically begins around day 7 and resolves by day 28 post-vaccination. No vaccine virus has been detected in throat swabs.

The intestinal immune response to the vaccine generates both systemic antibodies (IgG in the bloodstream) and mucosal antibodies (secretory IgA at mucosal surfaces, including the respiratory tract). This dual immunity protects the respiratory tract even though the vaccine is administered orally. The mucosal immune response in the gut and the respiratory tract are interconnected through the common mucosal immune system.

Live, non-attenuated (not weakened) virus. The vaccine contains viable strains of human adenovirus Types 4 and 7 prepared in human-diploid fibroblast cell cultures. Unlike some vaccines that use inactivated (killed) viruses, this vaccine uses fully active live virus to induce a mild intestinal infection that triggers lasting immunity.

If the tablets are swallowed whole as directed, no respiratory infection in the vaccine recipient has been documented—vaccine strain virus was not detected in throat swabs of any study participant. However, if the tablets are chewed or crushed, live virus could be released in the upper respiratory tract and potentially cause respiratory illness. This is why the no-chewing instruction is an absolute requirement.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Adenovirus Type 4 And Type 7 Vaccine, Live, Oral also looked for:

Annual Influenza VaccineRSV Vaccines (Abrysvo, Arexvy)Pneumococcal Vaccines (Prevnar 20, Pneumovax 23)COVID-19 Vaccines (Comirnaty, Spikevax)

31,300 have already found their meds with Medfinder.

Start your search today.

31K+
5-star ratingTrusted by 31,300 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?